meta
|
evidence
oncology
Living systematic review and meta-analysis
RET gene alteration defined cancer
2
glioblastoma (GB)
1
gene alteration target therapy
RET gene alteration targeted therapy
pralsetinib
selpercatinib
versus all
vs non active control
vs no control (uncontrolled study)
All patients
Top evidence (RCT only, high risk of bias excluded)
Best available evidence (possibly low or very low)
All RCTs
All studies (RCT+OBS)
study list
mapping
overview
meta-analysis
forest plot
NMA
excluded
button
bars
forest
bayes
pooled
summary
circles
objective responses (ORR)
objective responses (ORR)
RET gene alteration defined cancer
RET gene alteration defined cancer
versus no control (uncontrolled study)
pralsetinib vs. no control (uncontrolled study)
1
-
×
delta: difference in rate or median (if available)
×
Extraction panel open
An extraction panel is open